CONTEXT: Commercial announcement from Biodesix and Datavant to enhance their current lung cancer specific RWD biobank. It is hoped that the enhanced datasets will help pin future NSCLC treatments. IMPACT: Continue Reading
CONTEXT: More evidence of the increasing focus on RWE, with Aetion securing another significant round of funding. The company reports doubling of revenues last year and is planning to expand Continue Reading
CONTEXT: Another commercial announcement from Verantos. Regular readers will remember them inking a deal back in March with Amgen to launch an advanced RWE program focused on “high-validity” observational studies. Continue Reading
CONTEXT: Commercial announcement of a tie up between TriNetX and Takeda to develop the latter’s use of RWD in their overall trail design strategy. IMPACT: Low READ TIME: 1 min Continue Reading
CONTEXT: Yet another announcement of a venture capital funded company focused on commercialising real-world data sources | Are we opening up sources or slamming the door shut unless you have Continue Reading
CONTEXT: Commercial announcement of another in what is becoming the biggest rend this year – access to RWD. I don’t know about you, but I’m intrigued by the phrase “research Continue Reading
CONTEXT: Commercial announcement of a significant acquisition in the RWD space | Is this the biggest deal we will see this year or is there more to come? IMPACT: Medium Continue Reading
CONTEXT: Commercial announcement in decentralised trials IMPACT: Low READ TIME: 1 min Quality Level Mean [1 – 10]: 5 1. “Syneos Health has signed up with siteless trial specialist Science Continue Reading
CONTEXT: Commercial announcement of a tie up between AI provider and RWE data generation companies IMPACT: Low READ TIME: 1 min Quality Level Mean [1 – 10]: 6 1. “Through Continue Reading
CONTEXT: Commercial announcement of an RWE tie up with a major pharma company tying up with an RWE provider to generate “high validity” observational studies. Interesting phrase, that we are Continue Reading
